Month: July 2024
Company announcement no. 29 2024
Group CommunicationsBernstorffsgade 40DK-1577 København VTel. +45 45 14 00 00
8 July 2024Danske Bank share buy-back programme: Transactions in week 27
On 2 February 2024, Danske Bank A/S announced a share buy-back programme for a total of DKK 5.5 billion, with a maximum of 70 million shares, in the period from 5 February 2024 to 31 January 2025, at the latest, as described in company announcement no. 2 2024.
The programme is being carried out under Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbour Rules.
The following transactions were made under the share buy-back programme in week 27:
Number of shares
VWAP DKK
Gross valueDKKAccumulated,...
Sydbank share buyback programme: transactions in week 27
Written by Customer Service on . Posted in Public Companies.
Company Announcement No 29/2024Peberlyk 46200 AabenraaDenmark
Tel +45 74 37 37 37Fax +45 74 37 35 36
Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk8 July 2024
Dear Sirs
Sydbank share buyback programme: transactions in week 27On 28 February 2024 Sydbank announced a share buyback programme of DKK 1,200m. The share buyback programme commenced on 4 March 2024 and will be completed by 31 January 2025.
The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.
The following transactions have been made under the share buyback...
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery
Written by Customer Service on . Posted in Mergers And Acquisitions.
PRESS RELEASE
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discoverySynsight provides Iktos with an exclusive worldwide license to INSERM’s patented technology enabling high performance AI-driven in cellulo screening of modulators of protein-protein and RNA-protein interactions
The merger further complements Iktos’ AI-based drug discovery platform, that currently includes generative AI design, Retrosynthesis, and AI-driven automated synthesis capabilities by adding the key step of automated biological testingParis, July 8th 2024 – Iktos, a company specializing in Artificial Intelligence (AI) and Robotics for new drug design, announces the acquisition of Synsight, a French biotech company applying AI and high-content cell imaging to the...
LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS.
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Courtabœuf, July 08, 2024 at 7:00 a.m.LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS. ENCOURAGING OUTLOOK FOR FY 2024-25 DESPITE UNCERTAINTIES ON THE IMPACT OF FREIGHT COSTS AND EXCHANGE PERIODS AND ON CONSUMPTION.Annual sales: a historic fiscal year after 4 years of growth. Over the full fiscal year, which grew by 13.3% in 22-23, sales rose by a further 14.4% to €58.6m, compared with €51.2m a year earlier.Against a backdrop of a 3.6% appreciation of the euro against the US dollar in 1 year, and a very significant reduction in freight costs, Group margins logically improved as Lexibook succeeded in maintaining its prices, or even...
VIRBAC: exceptional first-half growth and guidance raised for 2024
Written by Customer Service on . Posted in Public Companies.
Compte tenu de la dynamique très positive de nos ventes observée sur le premier semestre (croissance du chiffre d’affaires attendue autour de 16% à taux de change constants1 et ~11% à taux de change et périmètre constants) qui devrait se poursuivre sur le second semestre, ainsi que d’un marché de la santé animale particulièrement porteur, la croissance du chiffre d’affaires 2024 à taux de change constants est attendue entre 12,5% et 14,5%1 (correspondant à une croissance désormais attendue de 7% à 9% à taux de change et périmètre constants).
Le ratio de “résultat opérationnel courant avant amortissement des actifs issus d’acquisitions” sur “chiffre d’affaires” devrait se consolider autour de 16% à taux de change et périmètre constants. A périmètre réel, l’impact des acquisitions Sasaeah et Globion devrait être légèrement accrétif sur ce...
VIRBAC announces executive management changes
Written by Customer Service on . Posted in Public Companies.
Sébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officerVirbac announces the resignation of Sébastien Huron from his position as chief executive officer. He will leave the Virbac Group’s executive management by September 30, 2024, to take a break from his professional life.
The board of directors has decided to appoint Habib Ramdani, currently chief financial officer and deputy chief executive officer, as interim CEO, to replace Sébastien Huron, while the appointments and compensation committee recruits the next chief executive officer. Backed by the board of directors, Habib will be able to count on the full support of the Group executive committee in executing the roadmap of our Virbac 2030 project.
The board of directors warmly thanks Sébastien for the tremendous...
EUROCOMMERCIAL PROPERTIES N.V.: 23.7% TAKE UP OF STOCK DIVIDEND AND PROGRESS SHARE BUYBACK PROGRAMME
Written by Customer Service on . Posted in Public Companies.
Date: 8 July 2024
Release: Before opening of Euronext
Please open the following link to read the full report including annexes:AttachmentFULL PRESS RELEASE
Corbion reports the progress of its € 20 million share buyback program 1 July – 5 July 2024
Written by Customer Service on . Posted in Public Companies.
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024.
During the week of 1 July up to and including 5 July 2024 a total of 70,284 shares were repurchased at an average price of € 19.1228 for a total amount of € 1,344,029.87.
To date, the total consideration for shares repurchased amounts to € 17,644,487.57 representing 88.82% of the overall share buyback program.
Corbion publishes on a weekly basis every Monday, an overview of the progress of the share buyback program on its website: https://www.corbion.com/Investor-relations/shareholder-information
This overview contains detailed information on the daily amount of repurchased shares and individual share purchase transactions.AttachmentWeekly progress on Corbion share buyback program 1 July – 5 July...
Unifiedpost Group closes the earlier announced divestment of FitekIN and ONEA.
Written by Customer Service on . Posted in Public Companies.
Press Release – Inside Information
La Hulpe, Belgium – 8 July 2024, 7:00 am. CET – Inside Information – Unifiedpost Group SA (Euronext Brussels: UPG) (“Unifiedpost, Group”), a leading provider of integrated business communications, today announces the successful closing of its previously announced divestment of the stand-alone products FitekIN and ONEA to Fitek Holding Oü, a company funded by Baltcap, for €7,2 million in cash.
Fitek Holding Oü, funded by Baltcap, a Private Equity Fund in the Baltic States and a former shareholder of Fitek, along with part of the existing management team, acquired the stand-alone products FitekIN and ONEA, including current customer contracts and intellectual property. The transaction was completed on July 5, 2024. Additionally, a mutual reselling agreement was established between Unifiedpost’s...
Q2 2024 Revenue Update
Written by Customer Service on . Posted in Public Companies.
OSLO, Norway (8 July 2024) – Based on preliminary reporting from operating units, management of TGS ASA (“TGS”) expects IFRS revenues for Q2 2024 to be approximately USD 224 million, compared to USD 206 million in Q2 2023.
POC revenues* are expected to be approximately USD 215 million, compared to USD 241 million in Q2 2023.
POC multi-client revenues are estimated at approximately USD 115 million versus USD 129 million in Q2 2023, with early sales of USD 49 million, compared to USD 66 million in Q2 2023, and late sales of approximately USD 66 million, up from USD 63 million in Q2 2023. Multi-client investments were approximately USD 52 million, compared to USD 86 million in Q2 2023.
Proprietary revenues are expected to be USD 100 million versus USD 113 million in Q2 2023.
“Without any special sales events, such as licensing...
